Cargando…

Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings

Detalles Bibliográficos
Autores principales:	Mer, Mervyn, Schultz, Marcus J., Adhikari, Neill K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	What's New in Intensive Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633616/ https://www.ncbi.nlm.nih.gov/pubmed/28620804 http://dx.doi.org/10.1007/s00134-017-4831-z

Ejemplares similares

Ventilatory support of patients with sepsis or septic shock in resource-limited settings
por: Serpa Neto, Ary, et al.
Publicado: (2015)

Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings
por: Thwaites, C. Louise, et al.
Publicado: (2016)

Recommendations for the management of severe malaria and severe dengue in resource-limited settings
por: Dondorp, Arjen M., et al.
Publicado: (2016)

What’s new in sepsis recognition in resource-limited settings?
por: Kwizera, Arthur, et al.
Publicado: (2016)

What’s new in ARDS: ARDS also exists in resource-constrained settings
por: Riviello, Elisabeth D., et al.
Publicado: (2016)

The ten pitfalls of lactate clearance in sepsis
por: Hernandez, Glenn, et al.
Publicado: (2018)

What’s new in the extracorporeal treatment of sepsis?
por: Pickkers, Peter, et al.
Publicado: (2017)

Paediatric sepsis: old wine in new bottles?
por: Schlapbach, Luregn J., et al.
Publicado: (2017)

Noradrenaline drives immunosuppression in sepsis: clinical consequences
por: Stolk, Roeland F., et al.
Publicado: (2020)

Automation to improve lung protection
por: Buiteman-Kruizinga, Laura A., et al.
Publicado: (2022)

Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial
por: Rochwerg, Bram, et al.
Publicado: (2017)

Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials
por: Chang, Wei, et al.
Publicado: (2018)

Effectiveness of a sepsis programme in a resource-limited setting: a retrospective analysis of data of a prospective observational study (Ubon-sepsis)
por: Booraphun, Suchart, et al.
Publicado: (2021)

Are large randomised controlled trials in severe sepsis and septic shock statistically disadvantaged by repeated inadvertent underestimates of required sample size?
por: Wong, Joshua L C, et al.
Publicado: (2018)

Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2019)

Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial
por: Lall, Ranjit, et al.
Publicado: (2021)

Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomised controlled trials
por: Yu, Hong, et al.
Publicado: (2016)

LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock
por: Guirgis, Faheem W, et al.
Publicado: (2019)

Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2016)

What’s new in subarachnoid hemorrhage
por: Smith, M., et al.
Publicado: (2014)

What’s new in bacterial meningitis
por: Brouwer, Matthijs C., et al.
Publicado: (2016)

What’s new on the HPA axis?
por: Hofland, Johannes, et al.
Publicado: (2015)

Pre-hospital transportation in Western countries for Ebola patients, comparison of guidelines
por: Coignard-Biehler, H., et al.
Publicado: (2015)

What’s new in the management of severe acute pancreatitis?
por: Mallédant, Yannick, et al.
Publicado: (2015)

What’s new about circulating biomarkers in pediatric acute lung disease
por: Moreira, Amélia, et al.
Publicado: (2016)

Goal-concordant care in the ICU: a conceptual framework for future research
por: Turnbull, Alison E., et al.
Publicado: (2017)

Intensive care medicine in 2050: the ICU in vivo
por: Ince, Can
Publicado: (2017)

What’s wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?
por: Dondorp, Arjen M., et al.
Publicado: (2017)

Should we rely on trials with disease- rather than patient-oriented endpoints?
por: de Grooth, Harm-Jan, et al.
Publicado: (2017)

Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D
por: Amrein, Karin, et al.
Publicado: (2018)

Statement paper on diversity for the European Society of Intensive Care Medicine (ESICM)
por: Weiss, Bjoern
Publicado: (2019)

ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units
por: Plachouras, Diamantis, et al.
Publicado: (2018)

New developments in the provision of family-centered care in the intensive care unit
por: Gerritsen, Rik T., et al.
Publicado: (2017)

What is new in selective decontamination of the digestive tract?
por: Kesecioglu, Jozef, et al.
Publicado: (2015)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
por: De Waele, Jan J., et al.
Publicado: (2020)

The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud
por: Wiedermann, Christian J., et al.
Publicado: (2018)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

Monitoring patient–ventilator interaction by an end-expiratory occlusion maneuver
por: Dianti, Jose, et al.
Publicado: (2020)

Airborne spread of SARS-CoV-2 while using high-flow nasal cannula oxygen therapy: myth or reality?
por: Haymet, Andrew, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3hjrq8fd6pekb28vtmnre689m